Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment

Abstract excerpt

Pharmacogenomics is the examination of how genetic variation influences drug metabolism and response, in terms of both efficacy and safety. In cardiovascular disease, patient-specific diplotypes determine phenotypes, thereby influencing the efficacy and safety of drug treatments, including statins, antiarrhythmics, anticoagulants and antiplatelets. Notably, polymorphisms in key genes, such as CYP2C9, CYP2C19,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood Pressure and Hypertension Studies
• Share to Hormonal Regulation and Hypertension
• Share to Pharmacogenetics and Drug Metabolism